BEGIN:VCALENDAR
PRODID:NingEventWidget-v1
VERSION:2.0
METHOD:PUBLISH
BEGIN:VTIMEZONE
TZID:America/New_York
X-LIC-LOCATION:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:19700308T020000
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=2SU
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:19701101T020000
RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
UID:2140535:Event:80219
DTSTAMP:20260603T093352Z
SUMMARY:Introduction to Adaptive Design for Clinical Trials
DESCRIPTION:Description:\nThis 2-day seminar includes an overview of A
 daptive Design, and an emphasis in group sequential design, sample siz
 e re-estimation, and Phase II/III Adaptive Seamless Designs.\nThe role
  of statistics in clinical trials incorporates the tools used to devel
 op a robust study, minimize bias, and assess efficacy of new treatment
 s as relates to comparison to competing therapies.\nRandomized clinica
 l trials remain the standard for clinical research. However, the cost 
 of a traditional randomized controlled trial especially in large sampl
 e sizes and long study duration, are limiting factors of innovation in
  the pharmaceutical and medical device arenas. A trial with an adaptiv
 e design can often result in lower costs and more efficiency by making
  use of interim analyses with data accumulated during the course of a 
 trial to modify a study, without compromising validity and integrity. 
 Adaptive designs also allow for checking trial assumptions and progres
 s before the conclusion of the study. Studies can be adapted for dose 
 response, patient accrual, and early stopping for futility or patient 
 safety concerns.\nHowever, there are special considerations in the pla
 nning and execution of a adaptive design to control Type I error rates
  and ensure consistency of treatment. In additional to protocol consid
 erations, the FDA and regulatory agencies also require particular assu
 rances that an adaptive design will incorporate flexibility at the exp
 ense of sacrificing study validity and patient safety.\nThe objective 
 of the seminar is to provide information that can be used immediately 
 by personnel involved in the design and analysis of clinical trials. 
 \n\nLocation:  Chicago, IL Date: September 6th & 7th, 2018 and Time: 
 9:00 AM to 6:00 PM\nVenue:  Will Be Announced soon\nPrice:\nPrice: $1
 ,295.00 (Seminar Fee for One Delegate)\nRegister for 5 attendees Price
 : $3,885.00 $6,475.00 You Save: $2,590.00 (40%)*\nRegister for 10 atte
 ndees Price: $7,122.00 $12,950.00 You Save: $5,828.00 (45%)*\n \n \n
 Sponsorship Program benefits for seminar\nFor More Information- https:
 //www.globalcompliancepanel.com/control/sponsorship\nContact us today!
 \nNetZealous LLC DBA GlobalCompliancePanel\njohn.robinson@globalcompli
 ancepanel.com\nToll free: +1-800-447-9407\nPhone: +1-510-584-9661\nWeb
 site: http://www.globalcompliancepanel.com\n \nRegistration Link - ht
 tps://www.globalcompliancepanel.com/control/globalseminars/~product_id
 =901891SEMINAR?seo\nFollow us on LinkedIn: https://www.linkedin.com/co
 mpany/globalcompliancepanel/\nLike us our Facebook page: https://www.f
 acebook.com/TrainingsAtGlobalCompliancePanel/\nFollow us on Twitter: h
 ttps://twitter.com/GCPanel\n \n\nFor more information visit https://m
 edtechiq.ning.com/events/introduction-to-adaptive-design-for-clinical-
 trials
DTSTART;TZID=America/New_York:20180906T090000
DTEND;TZID=America/New_York:20180907T180000
CATEGORIES:seminar
LOCATION:WILL BE ANNOUNCED SOON
WEBSITE:https://www.globalcompliancepanel.com/control/globalseminars/~
 product_id=901891SEMINAR?medtechiq_sep_2018_SEO
URL:https://www.globalcompliancepanel.com/control/globalseminars/~prod
 uct_id=901891SEMINAR?medtechiq_sep_2018_SEO
CONTACT:8004479407
ORGANIZER:NetZealous LLC DBA GlobalCompliancePanel
ATTACH;FMTTYPE="image/jpeg":http://storage.ning.com/topology/rest/1.0/
 file/get/2562020133?profile=original
ATTENDEE;ROLE=REQ-PARTICIPANT;PARTSTAT=ACCEPTED;RSVP=TRUE;CN="John Rob
 inson":https://medtechiq.ning.com/profile/JohnRobinson
END:VEVENT
END:VCALENDAR